Instead, prophylactic intravenous lansoprazole (30 mg) was administered to protect the gastric mucosa, alongside oral palonosetron hydrochloride for antiemesis and granulocyte colony-stimulating factor (G-CSF) to prevent leukopenia and neutropenia. This evidence concerns the gene CSF3 and Decreased total neutrophil count.